Clinical trial
Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
NCT04858308 is registered in ClinicalTrials.gov with Yooyoung Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
- Lead sponsor
- Yooyoung Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 29, 2021
- Completion date
- January 31, 2022
- Enrollment
- 554 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.